This report defines the problem and details historic efforts to combat these bad actors. It then provides an overview...
Reports
The PHAST Toolkit, which provides data-driven guidance to help communities coordinate their overdose response. Developed by the Centers for...
The NPS Discovery Toolkit is a consolidation of our program outcomes into a comprehensive document detailing relevant information about...
This report provides up-to-date information regarding the status of synthetic cannabinoid prevalence and positivity within the United States.
This report provides up-to-date information regarding NPS stimulant & NPS hallucinogen prevalence and positivity within the United States.
This report provides up-to-date information regarding the status of NPS benzodiazepine prevalence and positivity within the US.
This report provides up-to-date information regarding the status of NPS opioid prevalence and positivity within the United States.
The UNODC Early Warning Advisory (EWA) is the first global monitoring system on new psychoactive substances (NPS). Managed by...
Newly Reported Substances: The following substances were reported to NFLIS-Drug for the first time between July 1, 2022, and...
The Legislative Analysis and Public Policy Association (LAPPA) is monitoring the emergence of novel psychoactive substances (NPS) appearing on...
Trending Reports
- Trend Reports: cfsre NPS – Q1 2024 April 13, 2024
- NDEWS State Report: Alerts in New ork for 2023 April 12, 2024
- Federal Register: Placement of Etodesnitazene, NPyrrolidino Etonitazene, and Protonitazene in Schedule I April 11, 2024
- Federal Register: Extension of Temporary Placement of Butonitazene, Flunitazene, and Metodesnitazene in Schedule I April 11, 2024
- NDEWS Hotspot Alerts March 21 – 27, 2024 April 5, 2024